A pharmacovigilance analysis identified slight differences in reported adverse events with pegcetacoplan vs avacincaptad pegol, the only FDA-approved medications for geographic atrophy.
Steroid-induced glaucoma can present a number of issues, most notably increased IOP. Several ophthalmologists discussed identifying when and why this occurs and how to react…
With the ideal mix of retinal coverage and operational convenience, the retinal imaging space is prime for innovation
Cabozantinib is a vascular endothelial growth factor receptor tyrosine kinase inhibitor, a drug used as a therapy for several malignancies.
With 35+ lectures, a NASA keynote, and a river cruise through historic Heidelberg, this year’s symposium blends science and scenery
STODS can negatively impact patient satisfaction and surgical outcomes. Surgeons can reduce patient burden by identifying at-risk patients; optimizing the ocular surface before surgery; adopting…
The eye rubbing response to Demodex blepharitis may be causing other ocular issues, but fortunately, it is easy to identify with a simple slit-lamp examination.
To investigate regional variations in guttae distribution in Fuchs endothelial corneal dystrophy (FECD) and evaluate its relationship with anatomical ultraviolet (UV) protection by the eyelid.
Harrow acquired the U.S. commercial rights for Byqlovi through a licensing agreement with Formosa Pharmaceuticals, according to a press release.
FDA noted that the US phase 2 trial may serve as 1 of the 2 pivotal trials required for NDA filing.
GT delivers important information on recent research, surgical techniques, clinical strategies, therapeutics, and technology.
